Health
Drug May Reduce Tumor Volume in Neurofibromatosis – Technology Networks
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers have shown that the drug, cabozantinib, reduces tumor volume…
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children’s Hospital of Philadelphia (CHOP) as part of the Neurofibromatosis Clinical Trials Consortium have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1). The results of the Phase 2 clinical trial, co-chaired by Michael J. Fisher, MD at CHOP, were published recently in Nature Medicine.
“This is the second…
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
General16 hours agoAlbo and Dutton do battle for the Port of Darwin
-
Noosa News4 hours agoLune Has Launched a Loyalty Program to Reward Your Love of World-Famous Croissants and Other Tasty Pastries
-
Noosa News21 hours agoMeasles alert issued across popular south-east attractions